Skip to content

Mood state and brain electric activity in Ecstasy users

Alex Gamma, Edi Frei, Dietrich Lehmann, Roberto D Pascual-Marqui, Daniel Hell, Franz X. Vollenweider

Neuroreport 2000 DOI: 10.1097/00001756-200001170-00031 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Sample size 29
Population Ecstasy users and Ecstasy-naive controls
Topics Anxiety MDMA
Keywords Mood Electroencephalography Scalp Audiology Electrophysiology Cognition Developmental psychology Anatomy
Citations 81
Key findings Ecstasy users exhibited global increases in theta, alpha 1, and beta 2/3 power during eyes open, along with higher state depressiveness and emotional excitability.

Abstract

Resting EEG during open and closed eyes and subsequent mood ratings were obtained from 15 Ecstasy users and 14 Ecstasy-naive controls. Absolute spectral power on the scalp, and the three-dimensional, intracerebral distribution of neuroelectric activity using low resolution brain electromagnetic tomography (LORETA) were computed. LORETA revealed global increases of theta, alpha 1 and beta 2/3 power during eyes open in Ecstasy users, and spectral analyses revealed a right-posterior increase of alpha 2 power (confirmed by LORETA) and increased beta band activity during open eyes. Ecstasy users had higher levels of state depressiveness, emotional excitability and a trend-level increase in state anxiety. The observed differences may be related to regular exposure to Ecstasy or other illicit drugs, or may be pre-existing.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

  • Ecstasy users had higher state depressiveness and emotional excitability and a trend-level increase in state anxiety, alongside global EEG power increases.

    Synthesized

Comparable studies

Other observational and cohort studies on MDMA for anxiety, most cited first.

Study Year Design Participants
Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms Former chronic ecstasy users 2001 Observational cohort n = 29
No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study Regular polytoxic Ecstasy users and Ecstasy-naive controls 2001 Observational cohort
Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study Children and adolescents from the Dutch province of Zuid-Holland 2006 Prospective longitudinal population-based study n = 1,580
Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis Young adult MDMA/ecstasy users from the community 2007 Longitudinal study n = 402
Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure. Adult survivors of a single large-scale terrorist attack at a festival 2025 Observational cohort n = 343

Explore topics

By condition and practice